Publications by authors named "Eric Jadaud"

Claim this Profile
E
Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases.
Judith Porte, Caroline Saint-Martin, Thomas Frederic-Moreau, Marie-Ange Massiani, Laurence Bozec, Eric Jadaud

Biomedicines· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab-induced bullous pemphigoid after radiotherapy and abscopal effect.
Xavier Grimaux, Rémy Delva, Eric Jadaud, Anne Croue

Australas J Dermatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Florence Legouté, René-Jean Bensadoun, Valérie Seegers, Yoann Pointreau, Delphine Caron, Eric Jadaud

Radiat Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
Lionnel Geoffrois, Laurent Martin, Dominique De Raucourt, Xu Shan Sun, Yungan Tao, Eric Jadaud

J Clin Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
Yungan Tao, Anne Auperin, Christian Sire, Laurent Martin, Cedric Khoury, Eric Jadaud

J Clin Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Guillaume Janoray, Yoann Pointreau, Pascal Garaud, Sophie Chapet, Marc Alfonsi, Eric Jadaud

J Natl Cancer Inst· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External irradiation models for intracranial 9L glioma studies.
Sandrine Vinchon-Petit, Delphine Jarnet, Eric Jadaud, Loïc Feuvret, Emmanuel Garcion

J Exp Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for glioblastoma in the elderly.
Florence Keime-Guibert, Olivier Chinot, Luc Taillandier, Stéphanie Cartalat-Carel, Marc Frenay, Eric Jadaud

N Engl J Med· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.
Anne Clavreul, Manuel Delhaye, Eric Jadaud, Philippe Menei

J Neurooncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.
Philippe Menei, Eric Jadaud, Nathalie Faisant, Michèle Boisdron-Celle, Sophie Michalak

Cancer· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis